Zhuhai Rundu Pharmaceutical 润都股份
13 significant filings since 30 May 2026: 1 on share pledge, 5 on pledge released and 4 on change of interest, and 3 other kinds. The latest, on 29 Aug 2026: 关于持股5%以上股东减持计划实施完成的公告. On 13 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 196.70% to 216.04% from the same period a year earlier.
自 30 May 2026 起有 13 份重大公告：share pledge 1 份、pledge released 5 份、change of interest 4 份，另有 3 类。最新一份（29 Aug 2026）：关于持股5%以上股东减持计划实施完成的公告。13 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 196.70% 至 216.04%。
No broker reports from the last twelve months are held for this company. Brokers covered 1,059 of the 2,940 SZSE listings (36%) over the same period. 近十二个月无本公司研报；同期券商覆盖了 2,940 只 SZSE 证券中的 1,059 只（36%）。
No broker has changed its rating on this company in the reports held.
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。